Compare Indivior Pharmaceuticals Inc. Common Stock (INDV) vs Jumia Technologies AG - ADR (JMIA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Indivior Pharmaceuticals Inc. Common Stock vs Jumia Technologies AG - ADR — how do they compare? Indivior Pharmaceuticals Inc. Common Stock trades at $34.3 (market cap $4.03B), while Jumia Technologies AG - ADR trades at $5.7 (market cap $773.69M). The key difference: Indivior Pharmaceuticals Inc. Common Stock is far larger — about 5.2× Jumia Technologies AG - ADR's market cap, and Indivior Pharmaceuticals Inc. Common Stock is trading nearer its 52-week high, Jumia Technologies AG - ADR nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Indivior Pharmaceuticals Inc. Common Stock for 0 Days and Jumia Technologies AG - ADR for 29 Days on average.
| INDV | JMIA | |
|---|---|---|
Market Cap | $4.03B | $773.69M |
Volume | 2,781,171 | 1,611,098 |
Sector | Health | Consumer Cyclical |
52-Week High | $41.83 | $14.60 |
52-Week Low | $24.09 | $5.69 |
Typical Hold Time | 0 Days | 29 Days |
Enterprise Value | $4.32B | $739.34M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
JMIA trades at $5.91, down 3.27% on the day, with a bearish technical signal from moving averages and oscillators. The company reported Q2 2026 revenue growth and a narrowing EBITDA loss, supported by a recent $50 million capital raise from IFC. Analysts maintain a strong buy consensus with a $12.00 price target, citing operational improvements and a path to EBITDA breakeven by year-end.
The outlook hinges on JMIA achieving profitability targets amid persistent net losses and high cash burn. While analyst sentiment is bullish, execution risks in African markets and competitive pressures remain key concerns for investors evaluating the stock's recovery potential.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Indivior Pharmaceuticals Inc. Common Stock
Indivior Pharmaceuticals, Inc. is a pharmaceutical company focused on treatments for opioid use disorder and other addiction-related conditions, including its Suboxone film and tablet products.
Read more on INDV →About Jumia Technologies AG - ADR
Jumia Technologies AG is the pan-African e-commerce platform. The company's platform consists of a marketplace, which connects sellers with consumers. Its logistics service enables the shipment and delivery of packages from sellers to consumers, and the company's payment service facilitates transactions among participants active on its platform in selected markets. Jumia generates revenue from Sales of goods, Commissions, Fulfillment, Value-added services, and Marketing & Advertising. Its geographical segments are West Africa, North Africa, East & South Africa, Europe, and United Arab Emirates. The firm generates most of its revenue from the West Africa segment.
Read more on JMIA →
